Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease This is a preliminary, open-label, clinical trial designed to assess the efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients with ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have min...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Wellbutrin XL, Major Depressive Disorder and Breast Cancer - To evaluate the efficacy of bupropion extended release (Wellbutrin XL™) in the treatment of Major Depressive Disorder in women with breast cancer. - To evaluate the tolerabilit...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin The study consists of measurement of antidepressant-induced excessive sweating and its treatment with an experimental medication, terazosin (approved for hypertension), that will be added ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? This is a three-center, randomized, double-blind, fixed dose study designed to assess the efficacy, safety, and tolerability of a switch to vilazodone for sexual dysfunction associated wit...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) The study consists of measurement of antidepressant-induced excessive sweating and its treatment with an experimental medication, glycopyrrolate (approved to treat ulcers), which will be a...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune